Botanical species · safety record

Galium odoratum

The EFSA Compendium of Botanicals holds 22 constituent measurements for Galium odoratum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Galium odoratum (L.) Scop.

22Constituent measurements
0Safety records
6Cited sources
1Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1 licensed products naming Galium odoratum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Aerial parts

What the records describe

Constituents measured

  • Coumarin4
  • (+)-pulegone1
  • (-)-camphor1
  • 1,8-cineole1
  • 4-hydroxybenzoic acid1
  • Alkaloids1
  • Alpha-thujone1
  • Anthraquinones1
  • Beta-thujone1
  • Gallic acid1

Plant parts

  • Aerial part of plants18
  • Roots and other underground parts4

Preparations

  • Solvent extraction21
  • Essential oil1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
(+)-pulegoneAerial part of plantsSolvent extractionGC-MSResolve DOI
(-)-camphorAerial part of plantsSolvent extractionGC-MSResolve DOI
1,8-cineoleAerial part of plantsSolvent extractionGC-MSResolve DOI
Alpha-thujoneAerial part of plantsSolvent extractionGC-MSResolve DOI
Beta-thujoneAerial part of plantsSolvent extractionGC-MSResolve DOI
CoumarinAerial part of plantsSolvent extraction203 Milligram/kilogramLC-MS/MSResolve DOI
CoumarinAerial part of plantsSolvent extractionGC-MSResolve DOI
NonanalAerial part of plantsSolvent extractionGC-MSResolve DOI
4-hydroxybenzoic acidAerial part of plantsSolvent extraction17.5 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
AlkaloidsAerial part of plantsSolvent extractionLC-orbitrap-MSNo resolvable identifier
AnthraquinonesRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
CoumarinAerial part of plantsSolvent extraction≥ 2.47 Milligram/gramUV/VIS spectroscopy (photometry)No resolvable identifier
CoumarinAerial part of plantsSolvent extraction≤ 4.1 Milligram/gramUV/VIS spectroscopy (photometry)No resolvable identifier
Gallic acidAerial part of plantsSolvent extraction6.5 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Indole alkaloidsAerial part of plantsSolvent extractionLC-orbitrap-MSNo resolvable identifier
Iso-pinocamphoneAerial part of plantsEssential oil1 PercentGC-MSNo resolvable identifier
LucidinRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Naphthalene derivativesRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
P-coumaric acidAerial part of plantsSolvent extraction6.3 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Quinoline alkaloidsAerial part of plantsSolvent extractionLC-orbitrap-MSNo resolvable identifier
Quinolizidine alkaloidsAerial part of plantsSolvent extractionLC-orbitrap-MSNo resolvable identifier
RubiadinRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Burnett, Alan R., Thomson, Ronald H. Naturally occurring quinones. XIII. Anthraquinones and related naphthalenic compounds in Galium species and in Asperula odorata. Journal of the chemical society [section] c: organic, 1968, vol. (7), p. 854-7.
  2. Nardin, Tiziana., Piasentier, Edi., Barnaba, Chiara., Larcher, Roberto. Alkaloid profiling of herbal drugs using high resolution mass spectrometry. Drug testing and analysis, 2017, p. Ahead of Print.
  3. Baser, KHC., Ozek, T., Kirimer, N., Deliorman, D., Ergun, F. Composition of the essential oils of Galium aparine L. and Gallium odoratum (L.) Scop. from Turkey . Journal of essential oil research, 2004, vol. 16, no. 4, p. 305-307.
  4. WORNER, M., SCHREIER, P. THE COMPOSITION OF VOLATILES FROM WOODRUFF (GALIUM-ODORATUM L SCOP). Zeitschrift fur lebensmittel-untersuchung und-forschung, 1991, vol. 193, no. 4, p. 317-320. DOI
  5. Rychlik, Michael. Quantification of free coumarin and its liberation from glucosylated precursors by stable isotope dilution assays based on liquid chromatography-tandem mass spectrometric detection . Journal of agricultural and food chemistry, 2008, vol. 56, no. 3, p. 796-801. DOI
  6. Martin, B., Bodson, M., Baricevic, D., Novak, J., Pank, F. Investigation on the Morphological and Chemical Variability of Sweet Woodruff (Galium odoratum (L.) Scop.) in Southern Belgium . Iv international symposium on breeding research on medicinal and aromatic plants - isbmap2009, 2010, vol. 860, p. 61-66.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue